Cushing's Syndrome should be Cited as a Disease with High Cardiovascular Risk in Relevant Guidelines.

Cushing's Syndrome should be Cited as a Disease with High Cardiovascular Risk in Relevant Guidelines. Curr Vasc Pharmacol. 2018 Oct 05;: Authors: Koracevic G, Stojkovic M, Lovic D, Pavlovic M, Kostic T, Kutlesic M, Micic S, Koracevic M, Djordjevic M Abstract The intention of the paper is to give rationale and to suggest enlisting Cushing's syndrome (CS) amongst high cardiovascular (CV) risk conditions. A considerable amount of data refers to several-fold amplified mortality in CS. The causes are based on high occurrence of many CV risk factors in persons with CS (e.g., adiposity, arterial hypertension, dyslipidemia, as well as diabetes mellitus /DM/). Therefore, practically all individuals with CS have correspondingly the metabolic syndrome (MetSy), which is known as laden with high CV risk. Characteristically, in spite of the young average age, numerous of CS individuals dysplay a 'high' or a 'very high' CV risk, with the risk of a major CV event of over 20% in the following ten years. Although DM is listed as a condition with high cardiovascular risk CS is not, despite the fact that the greater part of CS population have either diabetes mellitus or diagnosed impaired glucose tolerance. CS is stated as a risk factor for aortic dissection in current guidelines, and it should be named as a disease with high CV risk (alike DM and chronic kidney disease) in the relevant guidelines, as well. PMID: 30289080 [PubMed - as supplied by publisher]
Source: Current Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Tags: Curr Vasc Pharmacol Source Type: research

Related Links:

Source: ClinicoEconomics and Outcomes Research - Category: Health Management Tags: ClinicoEconomics and Outcomes Research Source Type: research
Source: Neuropsychiatric Disease and Treatment - Category: Psychiatry Tags: Neuropsychiatric Disease and Treatment Source Type: research
ConclusionOur experimental findings offer a promising prospect for the use of HCY2 in the management of obesity through the regulation of AMPK/PGC1 pathways.Graphical Abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
DiscussionWe estimated higher risks of ALL in the offspring of women with pregestational diabetes. These results are consistent with previous findings and compatible with a role of prenatal glycaemic environment in childhood cancer aetiology.
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 20 July 2019Source: The Annals of Thoracic SurgeryAuthor(s): Yas Sanaiha, Behdad Kavianpour, Peter Downey, Raveendra Morchi, Richard J. Shemin, Peyman BenharashAbstractBackgroundIn the current era of value based healthcare delivery, an understanding of patient populations at greatest risk for mortality, complications, and readmissions after Thoracic Endovascular Aortic Repair (TEVAR) is warranted. Thus, the present study aimed to evaluate outcomes after TEVAR for patients with varying degrees of renal dysfunction.MethodsAll patients who underwent TEVAR from 2010-2015 in the NRD were ident...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Publication date: Available online 20 July 2019Source: The Annals of Thoracic SurgeryAuthor(s): Do Jung Kim, Sak Lee, Hyun-Chel Joo, Heirim Lee, Bumhee Park, Young-Nam Youn, Kyung-Jong Yoo, Seung Hyun LeeAbstractBackgroundLong-term outcomes of mitral valve replacement (MVR) recipients with pulmonary hypertension (PH) remain unclear. We determined the effect of concomitant PH on the clinical outcomes and late-onset progression of tricuspid regurgitation (TR) following MVR for rheumatic mitral stenosis.MethodsWe retrospectively reviewed 394 patients who underwent MVR between January 2000 and December 2013. PH was defined as ...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Arbutin protects HK-2 cells against high glucose-induced apoptosis and autophagy by up-regulating microRNA-27a. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2940-2947 Authors: Lv L, Zhang J, Tian F, Li X, Li D, Yu X Abstract Arbutin (ARB) has been widely used in skin pigmentation disorders. Nevertheless, the involvements of ARB in diabetic nephropathy (DN) are still unknown. We investigated the functions of ARB in high glucose (HG)-induced cell apoptosis and autophagy in HK-2 cells. Cell viability was examined through CCK-8 in HK-2 cells after disposal with 45 mM glucose and ARB (10-50&th...
Source: Artificial Cells, Nanomedicine and Biotechnology - Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research
The objective was therefore to assess insulin and amino acid responses following intake of a high protein meal in healthy horses and those with EMS. Six mature horses diagnosed with EMS and six age-matched control horses without EMS were used. Horses were fed 2 g/kg body mass (BM) of a high protein pellet (31% crude protein) at time 0 and 30 min, for a total of 4 g/kg BM, following an overnight fast. Blood samples collected during a 4 h period were analysed for plasma glucose, insulin, amino acids and urea concentrations.Glucose concentrations were not different between groups (P =&thinsp...
Source: The Veterinary Journal - Category: Veterinary Research Source Type: research
Publication date: Available online 20 July 2019Source: Biocatalysis and Agricultural BiotechnologyAuthor(s): Carolina Villadóniga, Ana María B. CanteraAbstractAngiotensin converting enzyme (ACE) plays a key role in regulating blood pressure and ACE inhibitors are first-line drugs for treating hypertension. Food protein-derived peptides with ACE inhibitory activity are natural and safe alternatives for both prevention and treatment of hypertension. The second most abundant whey protein, α-lactalbumin (ALA) was hydrolysed with proteases from Bromelia antiacantha Bertol., a native plant. Two new peptides w...
Source: Biocatalysis and Agricultural Biotechnology - Category: Biotechnology Source Type: research
This study elucidates the potential to use mitochondria from different donors (PAMM) to treat UVR stress and possibly other types of damage or metabolic malfunctions in cells, resulting in not only in-vitro but also ex-vivo applications. Gene Therapy in Mice Alters the Balance of Macrophage Phenotypes to Slow Atherosclerosis Progression https://www.fightaging.org/archives/2019/07/gene-therapy-in-mice-alters-the-balance-of-macrophage-phenotypes-to-slow-atherosclerosis-progression/ Atherosclerosis causes a sizable fraction of all deaths in our species. It is the generation of fatty deposits in blood vessel...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Cushing's Syndrome | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Heart | Hypertension | Metabolic Syndrome | Urology & Nephrology